Suntrust Banks’s VanEck Biotech ETF BBH Stock Holding History

Suntrust Banks’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$441K	Buy	3,740 +195	+6%	+$24.2K	﹤0.01%	996
2019 Q2	$458K	Sell	3,545 -34	-0.9%	-$4.19K	﹤0.01%	995
2019 Q1	$460K	Buy	3,579 +529	+17%	+$66.8K	﹤0.01%	962
2018 Q4	$338K	Buy	3,050 +417	+16%	+$50.4K	﹤0.01%	1011
2018 Q3	$358K	Sell	2,633 -133	-5%	-$17.3K	﹤0.01%	1022
2018 Q2	$332K	Sell	2,766 -78	-3%	-$9.19K	﹤0.01%	1067
2018 Q1	$342K	Sell	2,844 -16,646	-85%	-$2.09M	﹤0.01%	1009
2017 Q4	$2.43M	Buy	19,490 +1,145	+6%	+$146K	0.01%	460
2017 Q3	$2.46M	Buy	18,345 +245	+1%	+$31.9K	0.01%	463
2017 Q2	$2.27M	Buy	18,100 +863	+5%	+$104K	0.01%	463
2017 Q1	$2.05M	Buy	17,237 +3,045	+21%	+$356K	0.01%	463
2016 Q4	$1.53M	Buy	+14,192	New	+$1.54M	0.01%	662

Other funds holding BBH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Suntrust Banks's BBH Position: Q3 2019 in Review

Suntrust Banks increased its VanEck Biotech ETF (BBH) stake by 5.5% in Q3 2019, buying an estimated $24.2K and bringing the position to 3,740 shares worth $441K. The position accounts for ﹤0.01% of the portfolio, ranked #996.

Suntrust Banks first reported a position in BBH in Q4 2016 and has held it in 12 quarters since. The position peaked at $2.46M in Q3 2017. 78 funds tracked by Wall St. Rank hold BBH as of Q3 2019.

Suntrust Banks held 3,740 shares of VanEck Biotech ETF worth $441K as of Q3 2019.
Suntrust Banks bought 195 VanEck Biotech ETF shares in Q3 2019, an estimated $24.2K.
VanEck Biotech ETF made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #996 holding.
Suntrust Banks first reported a position in VanEck Biotech ETF in Q4 2016 and has held it in 12 quarters since.
Suntrust Banks's VanEck Biotech ETF position peaked at $2.46M in Q3 2017.
78 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.